Last update :
23/11/2022
References   References 4655  
Type : Journal
Web link : https://doi.org/10.1093/ajhp/zxab329

Research teams : Pittsburgh - Mount Nittany Medical Center
Authors : Holyk A, Lindner A, Lindner S, Shippert B
Title : Physical compatibility of Normosol-R with critical care medications used in patients with COVID-19 during simulated Y-site administration.
Reference : Am J Health-Syst Pharm ;79,1:27-33 2022

Level of Evidence : 
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionAmiodarone hydrochloride Anti-arrhythmic
Compatible 1,8 mg/ml + Normosol®
InjectionCaspofungin acetate Antifungal
Compatible 0,28 mg/ml + Normosol®
InjectionDexmedetomidine Sympathomimetic
Compatible 0,4 µg/ml + Normosol®
InjectionDobutamine hydrochloride Cardiotonic
Compatible 2 mg/ml + Normosol®
InjectionDopamine hydrochloride Cardiotonic
Compatible 1,6 mg/ml + Normosol®
InjectionEpinephrine hydrochloride Sympathomimetic
Compatible 16>>>32 µg/ml + Normosol®
InjectionLevofloxacine Antibiotic
Compatible 5 mg/ml + Normosol®
InjectionNorepinephrine bitartrate Sympathomimetic
Compatible 0,016 mg/ml + Normosol®
InjectionPantoprazole sodium Proton pump inhibitor
Incompatible 0,4 mg/ml + Normosol®
InjectionPhenylephrine hydrochloride Sympathomimetic
Incompatible 0,04 mg/ml + Normosol®
InjectionPiperacillin sodium / tazobactam Antibiotic
Compatible 40/5 mg/ml + Normosol®
InjectionVancomycin hydrochloride Antibiotic
Compatible 5 mg/ml + Normosol®
InjectionVasopressin Hormone
Compatible 0,2 UI/ml + Normosol®

  Mentions Légales